A Study to Compare the Safety and Imaging Pattern of Cyclotron-produced Technetium (CTC) vs. Generator-produced Technetium (G-PERT) in People With Thyroid Disorders Who Need Surgery
NCT02980679
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
25
Enrollment
OTHER
Sponsor class
Conditions
Thyroid Gland Diseases
Interventions
DRUG:
CTC
DRUG:
G-PERT
Sponsor
University of Alberta